Alnylam Seeks To Advance RNAi Further With Inex Delivery Technology
This article was originally published in The Pink Sheet Daily
Executive Summary
There is an "open invitation" to companies and academia to partner with Inex on RNAi therapies, Inex CEO tells "The Pink Sheet" DAILY.